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Abstract  
Objective: The objective of the present study was to determine the effects of 
concurrent LPS and cytokine priming, reflective of the in vivo milieu, on macrophage 
production of key periodontitis associated cytokines TNF, IL-1β and IL-6.  
Design: THP-1 cells were pre-treated with combinations of Porphyromonas 
gingivalis and Escherichia coli lipopolysaccharide (LPS), concurrently with polarising 
cytokines IFNγ and IL-4, or PMA as a non-polarised control.  Production of key 
periodontitis associated cytokines in response to subsequent LPS challenge were 
measured by enzyme – linked immunosorbent assay.  
Results: Compared with cells incubated with IFNγ or IL-4 alone in the “polarisation” 
phase, macrophages that were incubated with LPS during the first 24 h displayed a 
down-regulation of TNF and IL-1β production upon secondary LPS treatment in the 
“activation” phase. In all three macrophage populations (M0, M1 and M2), pre-
treatment with P. gingivalis LPS during the polarisation process led to a significant 
decrease in TNF production in response to subsequent activation by LPS (p = 0.007, 
p = 0.002 and p = 0.004, respectively). Pre-treatment with E. coli LPS also led to a 
significant down-regulation in TNF production in all three macrophage populations (p 
< 0.001). Furthermore, the presence of E. coli LPS during polarisation also led to the 
down-regulation of IL-1β in the M1 population (p < 0.001), whereas there was no 
measurable effect on IL-1β production in M0 or M2 macrophages. There was no 
significant effect on IL-6 production. 
Conclusions: Macrophages become refractory to further LPS challenge, whereby 
production of key periodontitis associated cytokines TNF and IL-1β is reduced after 
exposure to LPS during the polarisation phase, even in the presence of inflammatory 
polarising cytokines. This diminished cytokine response may lead to the reduced 
ability to clear infection and transition to chronic inflammation seen in periodontitis. 
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Introduction 
In healthy oral tissues, there is a fine balance in the interplay between host immune 
responses and resident microbes. When a shift occurs in the microbial community, 
or there is a dysfunctional immune response, homeostasis is disrupted and disease 
ensues. Periodontitis is a chronic inflammatory disease characterised by loss of 
periodontal ligament attachment to the tooth surface and irreversible, osteoclast 
driven alveolar bone resorption. The aetiology of periodontal disease is complex and 
incompletely understood. It has been established, however, that the presence of a 
subgingival dental plaque biofilm, concurrent with a susceptible host immune 
response, are required for progression of gingivitis into periodontitis [1]. Several 
“keystone” pathogens have been implicated in the initiation of periodontitis, including 
Porphyromonas gingivalis, among others [1].  
Bacteria in the gingival sulcus are protected from mechanical removal by tooth 
brushing, meaning that tissues of the periodontium are constantly exposed to 
bacteria and their associated antigens. Bacterial stimulation of host tissues is met 
with a retaliatory host inflammatory response. When inflammation is initiated, 
monocytes are recruited from the circulation into the tissues, where they differentiate 
into macrophages [2-4], directed by membrane bound and soluble factors that are 
encountered in their microenvironment. Dependant on these factors, macrophages 
will polarise within a spectrum of functional phenotypes, from pro-inflammatory 
(classically activated or M1) to anti-inflammatory, or regulatory (alternatively 
activated or M2) effector cells [5-8, 9{Murray, 2014 #1313, 10{Murray, 2014 #1313].  
Classically activated macrophages are polarized by granulocyte macrophage-colony 
stimulating factor (GM-CSF) and IFNγ, whilst alternatively activated macrophages 
(M2), can be polarized by M-CSF, IL-4, IL-13, IL-10 and immune complexes [5, 6, 
11, 12].  
Via the production of cytokines and chemokines, macrophages can orchestrate 
innate and adaptive immune responses in an attempt to control infection and repair 
damaged tissue. M1 type macrophages express high levels of pro-inflammatory 
cytokines, including TNF, IL-1β, and IL-6, which are attributed to inflammation and 
tissue destruction seen in periodontal disease [9, 13-15]. M2 type macrophages 
exhibit anti-inflammatory properties and express the regulatory cytokines, IL-10 and 
TGF-β, which negatively regulate M1 activity and contribute to the wound healing 
process. Both M1 and M2 macrophages are likely to be present in periodontal 
lesions [16]. Aberrant macrophage function has been implicated in the breakdown of 
immune tolerance [2, 17] and progression into chronic inflammation. Thus, 
periodontal disease is the manifestation of a dysregulated immune response, which 
fails to clear infection by periodontal pathogenic bacteria: A robust inflammatory 
response is need to clear infection, but is lacking in patients who succumb to 
periodontal disease. Various mechanisms have been proposed for this lack of robust 
response, including endotoxin tolerance. Endotoxin tolerance occurs when 
monocytes or macrophages are repeatedly exposed to bacterial products, such as 
LPS. It has been shown previously that monocytes and macrophages can become 
tolerant to LPS from periodontal pathogen, P. gingivalis.  
P. gingivalis has emerged as a popular periodontal research target because of its 
interesting immunomodulatory properties and implications as a keystone pathogen. 
The bacterium has a unique LPS structure and induces cytokine responses in a 
different way to that of the prototypical LPS from Escherichia coli [18-20], likely due 
to the different lipid A structures between these bacteria [18, 21]. Previous studies 
have examined the ability of periodontal pathogens to induce endotoxin tolerance in 
monocytes (if an infiltrating monocyte encounters LPS before any maturation / 
polarisation factors in an inflammatory lesion), or the effects of endotoxin tolerance 
on already polarised macrophages (encountering LPS after becoming polarised) [22-
26]. However, in vivo, infiltrating monocytes are likely to encounter both LPS and 
polarising cytokines at the same time, rather than encountering first one factor then 
the other in a linear fashion. No studies to date have described what effect this would 
have on the resulting polarised macrophages ability to produce the robust 
inflammatory response required to clear the infection. Thus, the present study aimed 
to examine the effects of concomitant exposure of monocytes to LPS and cytokines 
during the macrophage polarisation process on resulting macrophage production of 
key periodontitis associated cytokines (TNF, IL-1β and IL-6).  
 
Methods 
General cell culture 
THP-1 cells, a human pro-monocytic cell line derived from peripheral blood 
monocytic leaukeamia (ECACC 88081201), were maintained in RPMI 1640 (Lonza, 
Slough, UK) supplemented with 10% foetal bovine serum (LabTech, UK) and 1% L-
glutamine (Lonza, UK) in a humidified incubator at 37°C with 5% CO2. Cells were 
initially seeded at 4 x 105 cells / mL, routinely sub-cultured using 1:4 split ratios and 
maintained for no more than 10 passages. 
Generation of M1- and M2- like THP-1 macrophages  
The methodology was adapted from Tjiu et al [27]. 5 x 105 THP-1 were seeded in 
tissue culture plates and incubated with 5 ng/ml PMA for 6 h. Next, all the culture 
media was removed, including any non-adhered cells and was replaced with fresh 
media containing either (a) 5 ng/ml PMA, (b) 20 ng/ml IFNγ + 5 ng/ml PMA (c) 20 
ng/ml IL-4 + 5 ng/ml PMA for a further 18 h to generate unpolarised, M1-like and M2-
like macrophages, respectively. To measure cytokine responses of polarised THP-1 
cells to stimulation with Ultra-pure P. gingivalis LPS: a penta- acyltated, di-
phosphorylated lipid A isoform [17] (InvivoGen, CA), or E. coli K12 (InvivoGen, CA) 
LPS, cells were polarised according to the aforementioned protocol and stimulated 
with 1μg/mL LPS. Cells incubated in media alone served as negative controls. Upon 
completion of the incubation period, cell free supernatants were harvested and 
stored at -20°C until assay for cytokines by Enzyme Linked Immunosorbent Assay 
(ELISA). 
To measure the effects of LPS present in the polarising conditions, cells were 
cultured in the presence or absence of 1 μg/ml P gingivalis or E. coli LPS, either 
alone or in concert with polarising cytokines. Following polarisation, culture medium 
was removed and cells were washed 3 times in PBS. Fresh media was added 
containing either 1 μg/ml P. gingivalis or E. coli LPS to activate the macrophages.  
Media alone (no LPS) served as a negative control. After 24 h incubation, cell free 
supernatants were harvested and stored at -20ºC until assay for TNF, IL-1β and IL-6 
by ELISA. 
 
Enzyme Linked Immunosorbent Assay (ELISA)  
Paired antibody ELISAs (R&D, UK) were used to determine protein expression levels 
of TNF, IL-1β and IL-6 in cell free supernatants, according to manufacturer 
guidelines.  Absorbance was measured at 450nm in a Versa Max microplate reader 
(Molecular Devices, UK). Standard curve analysis was performed using SoftMax pro 
software and unknown concentrations of cytokines in the samples were calculated 
from the standard curve. 
Quantitative real time PCR 
Total RNA was isolated by acid guanidinium thiocyanate-phenol-chloroform 
extraction (as previously described [28]). RNA quantity was determined using 
NanoVue plus (GE Healthcare) spectrophotometer and purity was estimated using 
the A260/A280 ratio. cDNA was generated by reverse transcription reaction (Veriti, 
Applied Biosystems). Real- time PCR was performed using Power SYBR green PCR 
master-mix (Applied Biosystems). Test genes IL-10 (IL10) and TGF-β (TGFB1) were 
normalised against housekeeping gene, β-actin (ACTB). Primers were designed 
using Applied Biosystems software and purchased from Eurofins MWG Operon (UK) 
as illustrated in Table 1. 
Table 1: Primer sequences.  

















Data was acquired and analysed on the Applied Biosystems StepOne software 
(Applied Biosciences, UK). Human β actin 1 was used as the internal reference gene 
(housekeeping gene), and non-polarised (PMA treated) macrophages were used as 
calibrator samples. Differences in gene expression levels were calculated relative to 
the calibrator sample using the ΔΔ Ct method. 
Statistical analysis 
For comparison between two independent treatment groups, Student’s t-test (if the 
data were parametric) or Mann Whitney U test (if data were non-parametric) were 
used. In experiments where more than two treatment groups tested, a one-way 
analysis of variance (if the data were parametric) with the Holm-Sidak method for all 
pairwise comparison procedure, or the Kruskall-Wallis analysis of variance (if the 
data was non-parametric) were used to test for differences between groups. Results 
were considered significant if the p value was ≤ 0.005. 
 
Results  
M1 and M2 macrophages exhibit differential inflammatory cytokine responses 
to P. gingivalis LPS 
In the present study, THP-1 cells were treated with PMA for 6 h to differentiate them 
from pro-monocytes into adherent macrophage-like cells. M1- and M2- like 
macrophage populations were generated by treating the cells for a further 18 h with 
PMA and IFNγ (M1) or IL-4 (M2), respectively (method adapted from [29]).  
To measure the effects of P. gingivalis LPS on inflammatory cytokine production, 
cells were treated with 1µg/mL P. gingivalis LPS for 24 h. M1- like macrophages 
exhibited significantly higher levels of TNF, IL-1β and IL-6 production than the M2- 
like population (figure 1a), whereas M2 cells expressed higher levels of IL-10 and 
TGF-β mRNA than M1 (figure 1b). Basal levels of both IL-10 and TGF- β mRNA 
however were similar between M1 and M2 macrophages (figure 1b). Cells treated 
with IFN or IL-4 exhibited cytokine profiles typical of M1 and M2 like macrophages, 
respectively. As previously described 197, TNF, IL-1β and IL-6 production was up-
regulated to a greater extent by E. coli LPS than P. gingivalis LPS. This was evident 
in all macrophage polarisation states (figure 1a). 
 
Inflammatory cytokine production by M0, M1 and M2 macrophages is 
modulated by the presence of P. gingivalis during polarisation 
The present study revealed differential inflammatory cytokine production between 
polarised M1- and M2- like macrophages in response to P. gingivalis LPS. To reflect 
in vivo conditions, where naïve monocytes are recruited from bone marrow to the 
site of inflammation, the next experiments set out to see if this pattern of polarisation 
and inflammatory cytokine production could be modulated by exposure to LPS 
before the macrophages had polarised to either subset. To test this, macrophages 
were polarised as above, in the presence or absence of 1μg/mL P. gingivalis LPS. A 
third population of “unpolarised (M0)” macrophages were generated by treatment 
with PMA only, to test whether LPS alone had polarising properties.  Following 
polarisation, culture media were removed and cells were washed 3 x in PBS. To 
stimulate inflammatory cytokine production, the cells were treated again with 1ug/mL 
P. gingivalis LPS for 24 h. Cell free supernatants were collected and assayed for key 
periodontitis and M1 macrophage associated cytokines TNF, IL-1β and IL-6 by 
ELISA. 
In all three macrophage populations (M0, M1 and M2), pre-treatment with P. 
gingivalis LPS during the polarisation process led to a significant decrease in TNF 
production in response to subsequent activation by P. gingivalis LPS (Figure 2. p = 
0.007, p = 0.002 and p = 0.004, respectively). When treated with PMA alone, the 
“M0” macrophages produced 268 pg/mL TNF in response to P. gingivalis LPS 
challenge. However, when treated with PMA + P. gingivalis LPS, TNF production 
was diminished 10-fold to 27 pg/mL. When cells were polarised with IFNγ and P. 
gingivalis LPS, TNF production was also down-regulated (4-fold) in response to 
secondary challenge with P. gingivalis LPS. The same effect was seen in M2 
macrophages (5.5- fold decrease). M1 cells also down regulated their expression of 
Il-1β. There was no significant effect on levels of IL-1β in the M0 and M2 
macrophages. All cell types produced very little IL-6, so any diminishing effect could 
not be detected. 
 
Inflammatory cytokine production by M0, M1 and M2 macrophages is 
modulated by the presence of E. coli LPS during polarisation 
To assess whether the TNF down-regulation described above was specific to P. 
gingivalis, the experiments were repeated, but this time with the addition of E. coli 
LPS instead of P. gingivalis LPS during polarisation. At the end of the polarisation 
phase, culture media were removed and inflammatory cytokine production was 
stimulated by treatment with E. coli LPS. When compared to cells polarised with 
cytokines alone, the addition of E. coli LPS in the polarising media led to a significant 
down-regulation in TNF production in all three macrophage populations (figure 3. p < 
0.001). Furthermore, the presence of E. coli LPS during polarisation also led to the 
down-regulation of IL-1β in the M1 population (p < 0.001), whereas there was no 
measurable effect on IL-1β production in M0 or M2 macrophages. Similarly, to 
polarisation with P gingivalis LPS, the addition of E. coli LPS had no significant effect 
on IL-6 production compared with cytokines alone.  
 
Cross-modulation of inflammatory cytokine production by different LPS 
species 
Data from the experiments above reported that polarisation in the presence of P. 
gingivalis or E. coli LPS led to a down-modulation of TNF (and in the case of M1-
macrophages polarised with E. coli, IL-1β). E. coli LPS is the archetypal TLR4 ligand, 
whilst P. gingivalis LPS is purported to activate macrophages via TLR2. There is 
conflicting evidence in the literature regarding P. gingivalis LPS – TLR2 /4 signalling, 
with the likely explanation relating to the multiple lipid A moieties produced by P. 
gingivalis having different receptor binding properties. The next aim of the present 
study was to see if the two bacterial LPS species with different activating capacities 
were able to cross–modulate macrophage activation by one another.  
To assess this, macrophage populations were polarised in the presence (or 
absence) of either P. gingivalis or E. coli LPS, as above. Following polarisation, 
culture media were removed and macrophages were activated by the other LPS 
species. When M0, M1 and M2 – like macrophages were differentiated with PMA, 
cytokines and P. gingivalis LPS, then subsequently activated by E. coli LPS, TNF 
production was significantly down – regulated in all three macrophage populations 
(Figure 4a. M0: p < 0.001, M1: p = 0.04, M2: p < 0.001). In the M2 population, IL-1β 
production was also down- regulated (p=0.049). Similarly, when macrophages were 
polarised in the presence of E. coli LPS, then cross- activated by P. gingivalis LPS, 
TNF production was also down –regulated (Figure 4b. M0: p=0.03, M1: p=0.006, M2: 
p=0.024). In the M1 population, IL-1β production was also down regulated (p=0.002). 
 
Finally, we set out to test the effects of chronic exposure to low-dose LPS on 
macrophage inflammatory cytokine production. This time, the experiments were 
repeated but using 1 ng / mL of P. gingivalis or E. coli LPS in the polarising media. P. 
gingivalis at a concentration of 1 ng/ mL had no effect on consequent stimulation 
with either P. gingivalis or E. coli LPS; levels of cytokine production remained the 
same regardless of the presence of 1 ng/ mL P. gingivalis LPS in the polarising 
media. In contrast, the presence of E. coli in the polarising media led to the down-
regulation of TNF production in PMA and M2 – like macrophages, but not in M1 – 
like macrophages (Figure 5). There was no significant effect on IL-1β or IL-6 
production in any cell type (data not shown). 
 
Discussion 
In periodontal disease, infiltrating monocytes mature and polarise into macrophages 
with a range of effector phonotypes in response to locally derived factors such as 
IFNγ (generating inflammatory M1 macrophages) or IL-4 / 13 (generating reparatory, 
regulatory M2 macrophages). Given the cocktail of bacterial and host derived factors 
present in the periodontal lesion, it is unlikely that infiltrating monocytes will 
encounter first one factor then the other in a linear fashion, rather, they are likely to 
encounter both simultaneously. To date, no studies have sought to determine what 
effects this would have on the ability of the resulting macrophages to produce a 
robust response, needed to clear the infection. Therefore, we aimed to test what 
effects exposure to bacterial LPS during the polarisation of monocytes into effector 
macrophages would have on the resulting macrophages’ ability to produce the 
inflammatory cytokines needed to clear infection. Furthermore, we sought to 
examine whether the same effect was seen in non-polarised, M1 and M2 
macrophages, which have differing roles in disease progression. 
 
Cells from the human monocyte line, THP-1, were treated with PMA, PMA + IFNγ or 
PMA + IL-4 to generate un-polarised, M1 and M2 like macrophages, respectively. 
Polarised cells were challenged with P. gingivalis or E. coli LPS and assessed for 
protein production of key periodontal disease associated cytokines, TNF, IL1β and 
IL-6. As previously reported, P. gingivalis LPS elicited cytokine responses to a lesser 
extent than E. coli LPS [30]. Pre-treatment with IFNγ resulted in higher levels of 
cytokine production than un-polarised and IL-4 pre-treated cells. Holden et al also 
reported a similar finding, that M2- like macrophages produced TNF and IL-1β in 
response to P. gingivalis LPS, but to a lower level than that of M1- like macrophages 
[22]  
To assess the effects of concomitant exposure to LPS and polarising cytokines on 
macrophage cytokine production, THP-1 cells were given two, 24 hour treatments; 
the first a “polarising” treatment to differentiate the monocytes into macrophages, 
followed by an “activator” treatment to elicit cytokine production. “Un-polarised” 
macrophages were incubated with PMA for 24 h before washing and challenging 
with LPS for a further 24 h. The addition of priming cytokines (IFN and IL-4) into the 
differentiation media during the “polarising” treatment phase, lead to cytokine 
production characteristic of M1 and M2 macrophages in response to LPS added in 
the “activation” treatment phase. Compared to cells incubated with differentiation 
media alone in the “polarisation” phase, macrophages that were incubated with LPS 
during the first 24 h displayed a down-regulation of TNF and IL-1β production upon 
secondary LPS treatment in the “activation” phase. This effect was measured in 
response to both LPS species.  Un-primed macrophages displayed a cytokine profile 
similar to that of M2 macrophages, suggesting that in the absence of the M1-priming 
cytokine IFNγ, macrophages default to a less inflammatory phenotype. This also 
suggests that LPS as a stimulant alone cannot induce full inflammatory M1 
macrophage polarisation.  
A study by Zaric et al (2011) reports that TNF production is down- regulated in 
response to repeated exposure to P. gingivalis and E. coli LPS in THP-1 cells, but 
that IL-8 is down regulated only by repeated exposure to E. coli LPS, thus 
suggesting only partial tolerance is achieved by P. gingivalis LPS [31]. An earlier 
study by Martin et al (2001) reported that endotoxin tolerance induced by E. coli LPS 
in THP-1 led to down- regulation of TNF, IL-1β and IL-6, whereas endotoxin 
tolerance induced by P. gingivalis LPS only resulted in down-regulation of IL-1β 
production[32]. These findings differ from the present study in that TNF production 
was down regulated by prior exposure to P. gingivalis LPS. However, both studies 
agree that IL-1β was down regulated by prior exposure to either LPS species. In 
contrast to the Martin et al (2001) study, and in common with results from the 
present study, Muthukuru et al (2005) reported that TNF and IL-1β were down- 
regulated in response to repeated exposure of PBMCs to P. gingivalis LPS [33]. 
Dobrovolskaia et al (2003) reported that both E. coli LPS and synthetic TLR2 ligand   
PAM3CSK4 induced homotolerence but not heterotolerance in murine macrophages 
[34]. PAM3CSK4 pre-treatment up-regulated TNF production in response to E. coli 
LPS. P. gingivalis LPS also induced homotolerance, but like PAM3CSK, E. coli pre-
treatment up-regulated TNF production in response to secondary stimulus with P. 
gingivalis LPS. In contrast, results from the present study showed that E. coli LPS 
pre-treatment led to a down-regulation of TNF production when subject to a 
secondary stimulation by P. gingivalis LPS. However, the studies are in agreement in 
that as P. gingivalis pre-treatment led to a down-regulation of TNF production when 
subject to a secondary stimulation by E. coli LPS. Differences in responses reported 
in various studies may be attributable to the diverse macrophage differentiation 
protocols and different sources (thus antigenic structures) of LPS. 
In response to polarisation with either LPS species, the present study showed little 
difference in their ability to down- regulate cytokines. Previous studies have shown 
that P. gingivalis LPS is a weaker inducer of endotoxin tolerance than E. coli LPS 
[31, 32], and that this is down to differential use of TLRs and intracellular signalling 
pathways, with E. coli LPS reducing degradation of NFκB inhibitors IκKα and IκKβ 
and TLR4 surface expression upon secondary stimulation, whereas P. gingivalis 
LPS up-regulates TLR2 and CD14 expression and degrades inhibitory IκKβ, thereby 
rendering cells less responsive to tolerance [32]. 
Finally, the addition of E. coli LPS at a concentration of 1ng/mL in the polarising 
media resulted in the down-regulation of TNF in PMA and M2 like macrophages in 
response to a secondary LPS challenge (Figure 5). This yields two potentially 
interesting hypotheses; 1) E. coli LPS has the ability to modulate TNF production at 
low concentrations, whereas P. gingivalis LPS can only modulate TNF production at 
higher concentrations (1 μg/mL). 2) Neither LPS significantly modulated TNF 
production in M1 macrophages. It may be that given their anti-inflammatory nature, 
M2 like macrophages are more readily tolerised at lower concentrations than M1 to 
ensure that there is a robust inflammatory response, even to low concentrations of 
LPS. Translated into the clinical situation, this could mean that if P. gingivalis LPS is 
present in periodontal tissues at very low concentrations, low-level inflammatory 
cytokine production may continue and contribute to the tissue damage and bone 
resorption seen in periodontal disease. 
Conclusion 
Data from the present study demonstrated that macrophages become refractory to 
further LPS challenge after being exposed to LPS during the polarisation phase, 
even in the presence of polarising cytokines. This suggests that if infiltrating 
monocytes entering the infected tissues encounter LPS at the same time as host-
derived cytokines, they become refractory to further LPS challenge. This may be a 
protective mechanism engaged by the macrophages to limit collateral tissue damage 
in periodontal disease, as seen in endotoxin tolerance. It is particularly interesting 
that M1 like macrophages do not reach their full inflammatory potential if they meet 
LPS during their polarising stage, even in the presence of potent polarising agent, 
IFNγ. This may account for the change to chronicity witnessed clinically in 
periodontal diseases; if macrophages cannot reach full inflammatory potential, then 
infection may not be eradicated and inflammation becomes chronic. Further research 
to elucidate the mechanisms of macrophage polarisation and function in disease 
states will lay the groundwork to significantly improve management options for 
periodontitis, and other chronic inflammatory conditions such as peri-implantitis, and 
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Figure 1: (a) TNF, IL-1β and IL-6 production in response to LPS. THP-1 cells were 
incubated with IFNγ (M1) or IL-4 (M2). After 24 h, culture media were removed and 
cells were washed x3 in PBS. 1ug/mL Pg or Ec LPS was added to each cell type and 
incubated for 24 h. Cytokine protein expression was measured by ELISA. Data are 
means of 3 independent experiments +/- standard deviation. (b) Gene expression 
levels of IL-10 and TGF-β were measured in M1 and M2 macrophages stimulated 








Figure 2: Expression of inflammatory cytokines following repeated exposure of 
macrophages to P. gingivalis LPS. PMA, M1 and M2 macrophages were polarised in 
the presence or absence of P. gingivalis LPS (. After 24-hour incubation, media was 
removed and cells were washed x3 in PBS. Macrophages were then challenged with 
1μg/ml P. gingivalis LPS for 24 h. Cells incubated for 24 h in normal media (no LPS) 
served as negative controls. Supernatants were assayed for TNF, IL-1β and IL-6 by 
ELISA. Data are expressed as the mean of three independent experiments 
performed in triplicate wells +/- standard deviation. * indicates a statistically 
significant change in cytokine expression levels at p < 0.05. 
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Figure 3: Expression of inflammatory cytokines following repeated exposure of 
macrophages to E. coli LPS. PMA, M1 and M2 macrophages were polarised in the 
presence or absence of E. coli LPS. After 24-hour incubation, media was removed 
and cells were washed x3 in PBS. Macrophages were then challenged with 1μg/ml 
E. coli LPS for 24 h. Cells incubated for 24 h in normal media (no LPS) served as 
negative controls. Supernatants were assayed for TNF, IL-1β and IL-6 by ELISA. 
Data are expressed as the mean of three independent experiments performed in 
triplicate wells +/- standard deviation. * indicates a statistically significant change in 






Figure 4: Expression of inflammatory cytokines following cross-exposure of 
macrophages to P. gingivalis and E. coli LPS. PMA, M1 and M2 macrophages were 
polarised in the presence or absence of P. gingivalis or E. coli LPS. After 24-hour 
incubation, media was removed and cells were washed x3 in PBS. Macrophages 
were then cross - challenged with 1μg/ml E. coli (a) or P. gingivalis LPS (b) for 24 h. 
Cells incubated for 24 h in normal media (no LPS) served as negative controls. 
Supernatants were assayed for TNF, IL-1β and IL-6 by ELISA. Data are expressed 
as the mean of three independent experiments performed in triplicate wells +/- 
standard deviation. * indicates a statistically significant change in cytokine 




Figure 5: Expression of TNF following exposure of macrophages to E. coli LPS. 
PMA, M1 and M2 macrophages were polarised in the presence or absence of P. 
gingivalis or E. coli LPS. After 24-hour incubation, media was removed and cells 
were washed x3 in PBS. Macrophages were then challenged with 1μg/ml E. coli LPS 
for 24 h. Cells incubated for 24 h in normal media (no LPS) served as negative 
controls. Supernatants were assayed for TNF by ELISA. Data are expressed as the 
mean of three independent experiments performed in triplicate wells +/- standard 
deviation. * indicates a statistically significant change in cytokine expression levels at 
p < 0.05. 
 
